Vector-borne diseases (VBDs) continue to pose significant health challenges in India. These diseases, transmitted by vectors like mosquitoes, ticks, and fleas, account for more than 17% of all infectious diseases, causing substantial morbidity and mortality.
India's diverse climatic and geographical conditions make it a hotspot for VBDs such as Malaria, Dengue, and Chikungunya. Recent studies indicate a rising trend of these diseases, exacerbated by factors like urbanization, climate change, and inadequate public health infrastructure.
Efforts to control VBDs in India face numerous obstacles. Limited resources, insufficient disease surveillance, and lack of public awareness contribute to the persistence of these diseases. Furthermore, the increasing resistance of vectors to insecticides poses a significant challenge to control measures.
Integrated Vector Management (IVM) strategies have been effective in controlling VBDs. These strategies include vector surveillance, environmental management, biological control, and use of insecticides. Additionally, community participation and public health education are crucial for the successful implementation of these strategies.
Healthcare professionals play a pivotal role in combating VBDs. They are at the forefront of early detection, diagnosis, and treatment of these diseases. Moreover, they are instrumental in educating communities about preventive measures and the importance of environmental hygiene.
Despite the challenges, significant strides have been made in controlling VBDs in India. Continued investment in public health infrastructure, research, and education, along with the dedicated efforts of healthcare professionals, can further reduce the burden of these diseases. Understanding the prevalence and dynamics of VBDs is crucial in formulating effective public health strategies.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation